The annual review of clinical trials for Alzheimer’s highlights a growing number of active trials and drugs that could help ...

Education -- a proxy for cognitive reserve -- often correlates with better cognition, greater gray matter volume, improved ...

A new blood test uses what is known as biomarkers to identify a person’s Alzheimer’s disease status, changing how we monitor ...